Pharmaceutical

MSD extends peptide collaboration with IRBM

IRBM has extended its collaboration with MSD to develop peptide therapeutics, following results in coronavirus, cholesterol, and obesity.

Jun 23, 2023 - 20:00
MSD extends peptide collaboration with IRBM
IRBM has extended its collaboration with MSD to develop peptide therapeutics, following results in coronavirus, cholesterol, and obesity.
Read the original article

Tags:

Previous Article

Intercept winds down NASH programme after FDA pulls plug on Ocaliva

Next Article

FDA approves Duchenne gene therapy with hefty $3.2m price tag

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Merck to acquire Harpoon Therapeutics for $680 million

STAT+: Merck to acquire Harpoon Therapeutics for $680 m...

Jan 8, 2024

Microparticle analysis: methods and uses in the pharmaceutical industry

Microparticle analysis: methods and uses in the pharmac...

May 10, 2023

STAT+: Patients want test results now, and radiologists need time to explain. Can they meet in the middle?

STAT+: Patients want test results now, and radiologists...

Dec 1, 2023